跳至主要内容
临床试验/NCT03697681
NCT03697681已完成不适用

Protective Effect of Tranexamic Acid on Shedding of the Endothelial Glycocalyx in Patients Undergoing Spinal Fusion Surgery

Yonsei University1 个研究点 分布在 1 个国家目标入组 128 人开始时间: 2018年10月16日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
128
试验地点
1
主要终点
blood concentration of syndecan-1, heparan sulfate at the end of the surgery

研究概览

简要总结

The aim of this study was to determine whether the administration of tranexamic acid in patients undergoing lumbar spinal fusion surgery can inhibit damage in endothelial glycocalyx layer. As a prospective double blinded randomized placebo-controlled trial, the investigators detect and compare the changes in concentrations of serum syndecan-1 and heparan sulfate before and after surgery.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

盲法说明

triple blinded (Participant, Care Provider, investigator)

入排标准

年龄范围
30 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult patients with between 30 and 80 years scheduled for posterior lumbar spinal fusion surgery.

排除标准

  • emergency surgery
  • patients unable to make their own decisions, illiterate, foreigners
  • Allergy / hypersensitivity to Tranexamic acid
  • Current or past history or thrombosis / thromboembolism
  • patients who are taking oral contraceptives
  • Patients with renal insufficiency (eGFR 60 ml / min / 1.73 m 2 or less)
  • Patients receiving anticoagulants
  • pregnant and lactating women

研究组 & 干预措施

Glutamine

Experimental

Intravenous glutamine infusion perioperatively for 18 hours (8 hours before surgery and 10 hours after induction of anesthesia)

干预措施: Tranexamic acid (Drug)

Placebo

Placebo Comparator

placebo

干预措施: 0.9% NaCl (normal saline) (Drug)

结局指标

主要结局

blood concentration of syndecan-1, heparan sulfate at the end of the surgery

时间窗: within 5 minutes after the end of surgery (when thd surgical drape is removed)

blood concentration of syndecan-1, heparan sulfate at the end of the surgery

base blood concentration of syndecan-1, heparan sulfate

时间窗: within 1 hour before surgery(base concentration)

preoperative baseline serum levels of syndecan-1 and heparan sulfate

blood concentration of syndecan-1, heparan sulfate at 2 hours after surgery

时间窗: 2 hours after the end of surgery

blood concentration of syndecan-1, heparan sulfate at 2 hours after surgery

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验